Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August

Bulletin Express

08/17

Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:

1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.

2. Considering the declaration and payment of an interim dividend, subject to board approval.

3. Addressing any other routine business matters.

The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1179225137"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179225137\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179225137?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179225137","market":"us","top_or_hot":-1,"title":"Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August","media":"Bulletin Express","content":"<p>Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:</p>\n<p>1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.</p>\n<p>2. Considering the declaration and payment of an interim dividend, subject to board approval.</p>\n<p>3. Addressing any other routine business matters.</p>\n<p>The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-17 17:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:</p>\n<p>1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.</p>\n<p>2. Considering the declaration and payment of an interim dividend, subject to board approval.</p>\n<p>3. Addressing any other routine business matters.</p>\n<p>The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1179225137","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179225137","pubTimestamp":1786957628,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items: 1. Assessing and, if appropriate, approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"冠泽医疗将于8月31日审阅2026年上半年中期业绩及潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:\n1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.\n2. Considering the declaration and payment of an interim dividend, subject to board approval.\n3. Addressing any other routine business matters.\nThe notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}